Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgina Buck

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Trials|February 26, 2026
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetesVichithranie W Madurasinghe, Marion Mafham, Georgina Buck, et al.
Journal of Hematology & Oncology|October 15, 2011
The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XIChristina Halsey, Georgina Buck, Sue Richards, et al.
BMJ Open|February 26, 2025
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetesEmily Sammons, Louise Bowman, William Stevens, et al.
Contemporary Clinical Trials Communications|September 25, 2023
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degenerationEmily Sammons, Louise Bowman, William Stevens, et al.
Ophthalmology|January 18, 2024
ASCEND-Eye: Effects of Aspirin on Diabetic RetinopathyEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
BMC Ophthalmology|November 5, 2024
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trialEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
Ophthalmology|December 5, 2023
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic RetinopathyEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
American Heart Journal|April 15, 2018
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetesLouise Bowman, Marion Mafham, William Stevens, et al.
Trials|March 4, 2023
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trialSarah Parish, Georgina Buck, Theingi Aung, et al.
British Journal of Haematology|November 10, 2009
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII studyLena Rai, Anouska Casanova, Anthony V Moorman, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Trials|February 26, 2026
Factors associated with adherence to allocated treatment in the ASCEND trial: a mail-based randomised trial of aspirin and of omega-3 fatty acid supplementation in people with diabetesVichithranie W Madurasinghe, Marion Mafham, Georgina Buck, et al.
Journal of Hematology & Oncology|October 15, 2011
The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XIChristina Halsey, Georgina Buck, Sue Richards, et al.
BMJ Open|February 26, 2025
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetesEmily Sammons, Louise Bowman, William Stevens, et al.
Contemporary Clinical Trials Communications|September 25, 2023
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degenerationEmily Sammons, Louise Bowman, William Stevens, et al.
Ophthalmology|January 18, 2024
ASCEND-Eye: Effects of Aspirin on Diabetic RetinopathyEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
BMC Ophthalmology|November 5, 2024
Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trialEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
Ophthalmology|December 5, 2023
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic RetinopathyEmily L Sammons, Georgina Buck, Louise J Bowman, et al.
American Heart Journal|April 15, 2018
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetesLouise Bowman, Marion Mafham, William Stevens, et al.
Trials|March 4, 2023
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trialSarah Parish, Georgina Buck, Theingi Aung, et al.
British Journal of Haematology|November 10, 2009
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII studyLena Rai, Anouska Casanova, Anthony V Moorman, et al.
Pageof 4